Biotech | August 11, 2021
Moderna to set up mRNA manufacturing in Canada
The collaboration will support Canada with direct access to rapid pandemic response capabilities
The collaboration will support Canada with direct access to rapid pandemic response capabilities
The proposed acquisition will further bolster Strides US presence through acquisition of a multi dosage facility in the US.
The data should be submitted by August 12th 2021
Aditya Puri former MD of HDFC bank joins Solara board as chairman
Robust demand for the product across the Middle East, Africa and Latin America
The Phase III clinical trial for NONS is expected to be completed by Q4 2021.
The new greenfield manufacturing facility will be operated alongside the Guwahati facility as a parallel unit thereby helping mitigate the risks of a single-location operation
ADG20, a novel monoclonal antibody targeting the spike protein of SARS-CoV-2 and related coronaviruses
2DG has been given emergency approval by the Drug Controller General of India (DCGI) for use on COVID-19 patients in the country
The expanded laboratories and manufacturing facilities at Nansha are expected to come online between Q1 2022 and Q3 2022
Subscribe To Our Newsletter & Stay Updated
